| 1 |
18035190 | A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy. | 2007 Sep |
1 |
| 2 |
16150047 | A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study. | 2005 Oct |
1 |
| 3 |
8613982 | The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. | 1996 Apr 26 |
1 |
| 4 |
2499585 | Characterization of interaction of active-site serine mutants of tissue-type plasminogen activator with plasminogen activator inhibitor-1. | 1989 Jun 25 |
1 |
| 5 |
2962643 | The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage. | 1988 Feb 10 |
1 |
| 6 |
2412711 | A monoclonal antibody against human urokinase: the epitope structure and sequence homology with a human tissue-type plasminogen activator. | 1985 Sep |
2 |